Rankings
▼
Calendar
IMA Q4 2020 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$69M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$65,000
-97.7% YoY
Gross Profit
-$23M
-35903.1% margin
Operating Income
-$26M
-40081.5% margin
Net Income
-$26M
-40078.5% margin
EPS (Diluted)
$-1.86
QoQ Revenue Growth
-97.7%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$650,000
Balance Sheet
Total Assets
$168M
Total Liabilities
$269M
Stockholders' Equity
-$101M
Cash & Equivalents
$162M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$65,000
$3M
-97.7%
Gross Profit
-$23M
-$3M
-638.5%
Operating Income
-$26M
-$5M
-378.7%
Net Income
-$26M
-$5M
-410.0%
← FY 2020
All Quarters
Q1 2021 →